Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 214264
Company: ZYDUS PHARMS
Company: ZYDUS PHARMS
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| TOFACITINIB CITRATE | TOFACITINIB CITRATE | EQ 11MG BASE | TABLET, EXTENDED RELEASE;ORAL | Prescription | AB | No | No |
| TOFACITINIB CITRATE | TOFACITINIB CITRATE | EQ 22MG BASE | TABLET, EXTENDED RELEASE;ORAL | Prescription | AB | No | Yes |
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
|---|---|---|---|---|---|---|---|
| 08/19/2021 | ORIG-1 | Approval | STANDARD |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/214264Orig1s000ltr.pdf |
TOFACITINIB CITRATE
TABLET, EXTENDED RELEASE;ORAL; EQ 11MG BASE
TE Code = AB
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
|---|---|---|---|---|---|---|---|---|
| TOFACITINIB CITRATE | TOFACITINIB CITRATE | EQ 11MG BASE | TABLET, EXTENDED RELEASE;ORAL | Prescription | No | AB | 218462 | AUROBINDO PHARMA LTD |
| TOFACITINIB CITRATE | TOFACITINIB CITRATE | EQ 11MG BASE | TABLET, EXTENDED RELEASE;ORAL | Prescription | No | AB | 219442 | BIOCON PHARMA |
| TOFACITINIB CITRATE | TOFACITINIB CITRATE | EQ 11MG BASE | TABLET, EXTENDED RELEASE;ORAL | Prescription | No | AB | 216001 | SINOTHERAPEUTICS INC |
| TOFACITINIB CITRATE | TOFACITINIB CITRATE | EQ 11MG BASE | TABLET, EXTENDED RELEASE;ORAL | Prescription | No | AB | 214264 | ZYDUS PHARMS |
| XELJANZ XR | TOFACITINIB CITRATE | EQ 11MG BASE | TABLET, EXTENDED RELEASE;ORAL | Prescription | Yes | AB | 208246 | PFIZER |
TABLET, EXTENDED RELEASE;ORAL; EQ 22MG BASE
TE Code = AB
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
|---|---|---|---|---|---|---|---|---|
| TOFACITINIB CITRATE | TOFACITINIB CITRATE | EQ 22MG BASE | TABLET, EXTENDED RELEASE;ORAL | Prescription | No | AB | 214264 | ZYDUS PHARMS |
| XELJANZ XR | TOFACITINIB CITRATE | EQ 22MG BASE | TABLET, EXTENDED RELEASE;ORAL | Prescription | Yes | AB | 208246 | PFIZER |